1995S-0316
RPT 242
Volume 176-177
Volume 176
Cover
Letter
Letter
from CFSAN to Ingredia
Letter
from Ingredia to CFSAN
Declarative
Statement
New
Dietary Ingredient Notification for Lactium
Letter
from Ingredia to CFSAN
New
Dietary Ingredient Notification for Lactium
Appendix
1 - Lactium’s specifications
Appendix
2 - Lactium’s analysis certificates
Appendix
3 - Gomond, P. (Study Director); Miermon, M. (Technician). 2003. Acute Oral
Toxicity Test in the Rat. Acute Toxic Class Method: Test Substance: ING 911
- DRAFT. [Test Facility] EVIC; France. [Sponsor] INGREDIA; France (July 17,
2003). Study: Tj 290 / 03-2070.
Appendix
4 - OECD. 1997. In vitro Mammalian Cell Gene Mutation Test (Guideline No. 476).
In: Guidelines for the Testing of Chemicals. Organisation for Economic Co-Operation
and Development (OECD); Paris, Vol. 2.
Appendix
5 - Dufour, P. (Study Director); Miermon, M. (Responsible Technician); Urbaniak,
R. (Anatomopatholigist). 2003. Oral Toxicity Test After 28-Day Repeated Administration
in the Rat of a Food Supplement ING 911 - DRAFT. [Test Facility] EVIC; France.
[Sponsor] INGREDIA; France (Oct. 10, 2003). Study: Tj 289 / 03-2070.
Appendix
6 - Forichon, A. (Study Director); Aujoulat, M. (Deputy Study Director); Withers,
P. (Quality Assurance); Demagny, B. (Study Monitor). 2001. ING 911 - In Vitro
Mammalian Cell Gene Mutation Test on L5178Y Mouse Lymphoma Cells TK+/- (Microtitre
Method). [Test Facility] MDS Pharma Services; France. [Sponsor] INGREDIA; France
(Jan. 24, 2001). Study Number: 755/002.
Appendix
7 - Forichon, A. (Study Director); Aujoulat, M. (Deputy Study Director); Withers,
P. (Quality Assurance); Demagny, B. (Study Monitor). 2000. ING 911 - Bacteria
Reverse Mutation Test (Plate Incorporation and Preincubation Methods). [Test
Facility] Pheonix International Preclinical Services Europe; France. [Sponsor]
INGREDIA; France (June 16, 2000). Pheonix International Study Number: 755/001;
Sponsor Study Number: ING 911/AMTE/E COLI, continued
Volume 177
Appendix
8 - Cover sheet
Appendix
8 - GB : Messaoudi, M.; Nejdi, A.; Marchand, T. 2001. Study Report Version 1.0.
Study of the Effects of “ING 911” Hydrolysate, Given at a 150 mg/kg
Daily Dose Throughout Pregnancy, on the Maternal Behaviour and the Physical,
Neurmotor and Behavioural Development of Youngs Between Birth and Adulthood
in Wistar Rat. [Investigator] Centre de Recherche ETAP - Applied Ethology; France.
[Sponsor]
INGREDIA; France (Nov., 2001). Protocol Code: INGREDIA - 18/1100/ING 911 - Behavioural
Toxicology (Experimental Period: Jan. - July 2001).
Appendix
8 - F : Original in French
Appendix
9 - GB : Plenat, F. 2001a. Study Report: Study of the Effects of the “ING
911” Hydrolysate, Given Orally to Wistar Mother Rats Throughout Pregnancy.
[Test Facility] Laboratoire d’Anatomie Pathologique - Faculte de Medecine;
France. [Sponsor] INGREDIA; France (May, 2001). Protocol Code: INGREDIA-8/100/Pathoanatomy
(Experimental Period: Feb. - Apr. 2001).
Appendix
9 - F : Original in French
Appendix
10 - Cover Sheet
Appendix
10 - GB : Plenat, F. 2001 b. Study Report: Study of the Effects of the “ING
911” Hydrolysate, Given to Female Rats Throughout Pregnancy, on Internal
and External Malformations in Young Second-Generation Wistar Rats. [Test Facility]
Laboratoire d’Anatomie Pathologique - Faculte de Medecine; France. [Sponsor]
INGREDIA; France (Oct., 2001). Protocol Code: INGREDIA-13-2/0501/Pathoanatomy-F2
(Experimental Period: July-Aug. 2001).
Appendix
10 - F: Original in French
Appendix
11 - Miclo, L., Perrin, E., Driou, A., Papadopoulos, V., Boujrad, N., Vandresse,
R., Boudier, J., Desor, D., Linden, G., and Gaillard, J.; Characterization of
a-Casozepine, a Tryptic Peptide from Bovine alpha-s1 Casein with Benzodiazepine-like
Activity. The FASEB Journal express article 10.1096/fj.00-0685fje. Published
online June 8, 2001.
Appendix
12 - Cover Page
Appendix
12 - Messaoudi, M, Jung P, Grasmuck V, Desor F, Desor, D. Addictive effect of
the product <<ING 912>> intraperitonally administered in the Conditioned
Place Reference in the male Wistar Rat. [Investigator] Centre de Recherche ETAP
- Applied Ethology; France. [Sponsor] INGREDIA; France (Oct., 1998). Protocol
Code: INGREDIA - 3/02980/ING 912 - (Experimental Period: April - May 1998).
Appendix
13 - Cover Page
Appendix
13 - Messaoudi, M, Desor F, Desor, D. Assessment of behavioral effects of <<ING
913>> peptide. Centre de Recherche ETAP - Applied Ethology; France. [Sponsor]
INGREDIA; France (Dec., 1999). Protocol Code : INGREDIA 01/0399- (Experimental
Period : April 1999)
Appendix
14 - Cover Page
Appendix
14 - Messaoudi, M, Grasmuck V, Desor F, Desor, D. Tolerance to the anxiolytic
effect of the product <<ING 913>> intraperitoneally administered
on conditioned defensive burying in the male Wistar Rat. [Investigator] Centre
de Recherche ETAP - Applied Ethology; France. [Sponsor] INGREDIA; France (October,
1998). Protocol Code : INGREDIA-7/0698 - (Experimental Period: July 1998).
Appendix
15 - Cover Page
Appendix
15 - GB: Bresson, JL; Elghozi, JL; Desor, D; Messaoudi, M. [Sponsor] INGREDIA;
France (July 2000). Protocol Code: INGREDIA-04/0799 - (Experimental Period:
September 1999 -February 2000).
Appendix
15 - F : Original in French
Appendix
16 - Cover Page
Appendix
16 - GB : Bourdon, L. (Main Investigator); Canini, F.; Lanoir, D.; Martin, S.;
Fidier, N.; d’Aleo, P.; Roux, A.; Denis, J.; Chapotot, F.; Becq, G.; Lanoir,
D. (Author). 2003. Analysis of the Chronic Psychophysiological Effects of ING
911. [Sponsor INGREDIA; France] (Mar., 2003). Study: Tj 289/03-2070.
Appendix
16 - F : Original in French
Appendix
17 - U.S. EPA. 1997. Exposure Factors Handbook. U.S. Environmental Protection
Agency (U.S. EPA); Washington, DC. [PB98-124217].
Appendix
18 - Fennema, O.R. (Ed.). 1996. Food Chemistry (3rd Ed.). Marcel Dekker; New
York, pp. 847.
Appendix
19 - Holland, B., Welch, A.A., Unwin, I.D., Buss, D.H., Paul, A.A., and Southgate,
D.A.T. (Eds.). 1996. Milk and Milk Products. &-I: McCance and Widdowson’s
The Composition of Foods (5th Ed.). The Royal Society of Chemistry; Cambridge,
pp. 73-74.
Appendix
20 - U.S. EPA. 2002. Child-Specific Exposure Factors Handbook (Interim Report).
U.S. Environmental Protection Agency (U.S. EPA), National Center for Environmental
Assessment; Washington, DC. [EPA-600-P-00-002B].